Choose your health insurer consciously
KiesZuiver compares health insurers based in part on investments in companies involved in Israeli settlements and on the proportion of preferred medicines supplied by Teva.
Organizations KiesZuiver raises concerns about
The points below come from KiesZuiver and the sources it cites.
Achmea
Concerns- over $1.7 billion Citing DBIO research, KiesZuiver reports that Achmea invests more than $1.7 billion in companies involved in the Israeli settlement economy.
- Christelijke Zorgverzekeraar
- De Friesland
- FBTO
- Interpolis
- Zilveren Kruis
ASR
Concerns- over $1.7 billion Citing DBIO research, KiesZuiver reports that ASR invests more than $1.7 billion in companies involved in the Israeli settlement economy.
- a.s.r.
ONVZ
Concerns- Teva share
- 19% of preferred medicines
- According to KiesZuiver, ONVZ reported that 19% of its preferred medicines are supplied by Teva.
- VvAA
DSW
Concerns- Teva share
- 11% of preferred medicines
- According to KiesZuiver, DSW reported that 11% of its preferred medicines are supplied by Teva.
- Stad Holland
Alternatives named by KiesZuiver
KiesZuiver assesses these organizations more favourably. ICPalestina has not investigated these assessments itself and cannot guarantee that an alternative is entirely ethical.
KiesZuiver states that currently no health insurer has a completely 'clean' investment policy and presents the listed options as relative alternatives.
VinkVink
Alternative- Teva share
- 4% of preferred medicines
Zorg en Zekerheid
Alternative- Teva share
- 4% of preferred medicines
- AZVZ
Menzis
Alternative- Teva share
- 4% of preferred medicines
- Anderzorg
Aevitae
Alternative- Teva share
- 4% of preferred medicines
Salland
Alternative- Teva share
- 4% of preferred medicines
Also listed by KiesZuiver, for comparison
VGZ
For comparison- Teva share
- 7% of preferred medicines
- UMZ
- IZZ
- Univé
- IZA
- Zekur
- United Consumers
CZ
For comparison- Teva share
- 9% of preferred medicines
- Just
- OHRA
- Nationale Nederlanden
Background and practical information
How KiesZuiver compares
KiesZuiver says its assessment focuses mainly on investments in companies identified by DBIO as involved in Israeli settlements, the percentage of preferred Teva medicines, and insurers' sustainability policies.
Why Teva?
KiesZuiver considers Teva relevant because it is an Israeli pharmaceutical company and points to statements and reporting concerning support for Israel and the Israeli military. KiesZuiver refers to StopTeva among its supporting sources.
This information comes from KiesZuiver
The assessments, amounts and percentages on this page are taken from KiesZuiver. ICPalestina passes them on but has not investigated them itself. KiesZuiver's page has the full reasoning, the sources and the current figures.
View information and sources at KiesZuiver (opens in a new window)